The Healthcare Leadership Council (HLC) urges the U.S. Trade Representative to strengthen and restore intellectual property protections—especially for biopharmaceuticals—in the USMCA during its Joint Review, arguing this will boost innovation, investment, and North American competitiveness.
HLC comments support strengthening intellectual property provisions of USMACA
- Topics: Competition, Innovation
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
Group letter urging congressional leadership to include H.R. 3514/S.1816, Improving Seniors Timely Access to Care Act in year-end legislative package
The Healthcare Leadership Council (HLC) joined more than 300 healthcare organizations in supporting the Improving Seniors’ Timely Access to Care Act (H.R. 3514/S. 1816) and urging congressional leadership to include the bipartisan legislation in a y…
HLC letter to Congressional Leadership on end of year priorities
As Congress works to finalize year-end legislation, HLC urges congressional leaders to work together to advance bipartisan healthcare policies that address pressing challenges facing patients and the healthcare sector. With the 119th Congress drawin…
HLC letter to House sponsors in support of H.R. 4464, the “Preventive Health Savings Act”
HLC sent letters to bipartisan House and Senate sponsors of H.R. 4464/S. 3204 the Preventive Health Savings Act reiterating our strong support for the legislation. The bill would allow Congress to request Congressional Budget Office (CBO) estimates …